Global Pediatric Drugs and Vaccines Market Insights, Forecast to 2031

Report ID: 1666983 | Published Date: Oct 2024 | No. of Page: 111 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Pediatric Drugs and Vaccines Product Introduction
    1.2 Market by Type
        1.2.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Diphtheria
        1.2.3 Influenza
        1.2.4 Hepatitis
        1.2.5 Pneumococcal Diseases
        1.2.6 Meningococcal Diseases
        1.2.7 Mumps
        1.2.8 Others
    1.3 Market by Application
        1.3.1 Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Newborn
        1.3.3 Infant
        1.3.4 Child
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Pediatric Drugs and Vaccines Sales Estimates and Forecasts 2017-2028
    2.2 Global Pediatric Drugs and Vaccines Revenue Estimates and Forecasts 2017-2028
    2.3 Global Pediatric Drugs and Vaccines Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Pediatric Drugs and Vaccines Sales by Region
        2.4.1 Global Pediatric Drugs and Vaccines Sales by Region (2017-2022)
        2.4.2 Global Sales Pediatric Drugs and Vaccines by Region (2023-2028)
    2.5 Global Pediatric Drugs and Vaccines Revenue by Region
        2.5.1 Global Pediatric Drugs and Vaccines Revenue by Region (2017-2022)
        2.5.2 Global Pediatric Drugs and Vaccines Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Pediatric Drugs and Vaccines Sales by Manufacturers
        3.1.1 Global Top Pediatric Drugs and Vaccines Manufacturers by Sales (2017-2022)
        3.1.2 Global Pediatric Drugs and Vaccines Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pediatric Drugs and Vaccines in 2021
    3.2 Global Pediatric Drugs and Vaccines Revenue by Manufacturers
        3.2.1 Global Pediatric Drugs and Vaccines Revenue by Manufacturers (2017-2022)
        3.2.2 Global Pediatric Drugs and Vaccines Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Pediatric Drugs and Vaccines Revenue in 2021
    3.3 Global Pediatric Drugs and Vaccines Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Pediatric Drugs and Vaccines Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Pediatric Drugs and Vaccines Sales by Type
        4.1.1 Global Pediatric Drugs and Vaccines Historical Sales by Type (2017-2022)
        4.1.2 Global Pediatric Drugs and Vaccines Forecasted Sales by Type (2023-2028)
        4.1.3 Global Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2028)
    4.2 Global Pediatric Drugs and Vaccines Revenue by Type
        4.2.1 Global Pediatric Drugs and Vaccines Historical Revenue by Type (2017-2022)
        4.2.2 Global Pediatric Drugs and Vaccines Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2028)
    4.3 Global Pediatric Drugs and Vaccines Price by Type
        4.3.1 Global Pediatric Drugs and Vaccines Price by Type (2017-2022)
        4.3.2 Global Pediatric Drugs and Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Pediatric Drugs and Vaccines Sales by Application
        5.1.1 Global Pediatric Drugs and Vaccines Historical Sales by Application (2017-2022)
        5.1.2 Global Pediatric Drugs and Vaccines Forecasted Sales by Application (2023-2028)
        5.1.3 Global Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2028)
    5.2 Global Pediatric Drugs and Vaccines Revenue by Application
        5.2.1 Global Pediatric Drugs and Vaccines Historical Revenue by Application (2017-2022)
        5.2.2 Global Pediatric Drugs and Vaccines Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2028)
    5.3 Global Pediatric Drugs and Vaccines Price by Application
        5.3.1 Global Pediatric Drugs and Vaccines Price by Application (2017-2022)
        5.3.2 Global Pediatric Drugs and Vaccines Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Pediatric Drugs and Vaccines Market Size by Type
        6.1.1 North America Pediatric Drugs and Vaccines Sales by Type (2017-2028)
        6.1.2 North America Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
    6.2 North America Pediatric Drugs and Vaccines Market Size by Application
        6.2.1 North America Pediatric Drugs and Vaccines Sales by Application (2017-2028)
        6.2.2 North America Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
    6.3 North America Pediatric Drugs and Vaccines Market Size by Country
        6.3.1 North America Pediatric Drugs and Vaccines Sales by Country (2017-2028)
        6.3.2 North America Pediatric Drugs and Vaccines Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Pediatric Drugs and Vaccines Market Size by Type
        7.1.1 Europe Pediatric Drugs and Vaccines Sales by Type (2017-2028)
        7.1.2 Europe Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
    7.2 Europe Pediatric Drugs and Vaccines Market Size by Application
        7.2.1 Europe Pediatric Drugs and Vaccines Sales by Application (2017-2028)
        7.2.2 Europe Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
    7.3 Europe Pediatric Drugs and Vaccines Market Size by Country
        7.3.1 Europe Pediatric Drugs and Vaccines Sales by Country (2017-2028)
        7.3.2 Europe Pediatric Drugs and Vaccines Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Pediatric Drugs and Vaccines Market Size by Type
        8.1.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Type (2017-2028)
        8.1.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
    8.2 Asia Pacific Pediatric Drugs and Vaccines Market Size by Application
        8.2.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Application (2017-2028)
        8.2.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
    8.3 Asia Pacific Pediatric Drugs and Vaccines Market Size by Region
        8.3.1 Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2017-2028)
        8.3.2 Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Pediatric Drugs and Vaccines Market Size by Type
        9.1.1 Latin America Pediatric Drugs and Vaccines Sales by Type (2017-2028)
        9.1.2 Latin America Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
    9.2 Latin America Pediatric Drugs and Vaccines Market Size by Application
        9.2.1 Latin America Pediatric Drugs and Vaccines Sales by Application (2017-2028)
        9.2.2 Latin America Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
    9.3 Latin America Pediatric Drugs and Vaccines Market Size by Country
        9.3.1 Latin America Pediatric Drugs and Vaccines Sales by Country (2017-2028)
        9.3.2 Latin America Pediatric Drugs and Vaccines Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Type
        10.1.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Type (2017-2028)
    10.2 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Application
        10.2.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Application (2017-2028)
    10.3 Middle East and Africa Pediatric Drugs and Vaccines Market Size by Country
        10.3.1 Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck & Co., Inc. (USA)
        11.1.1 Merck & Co., Inc. (USA) Corporation Information
        11.1.2 Merck & Co., Inc. (USA) Overview
        11.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck & Co., Inc. (USA) Recent Developments
    11.2 Abbott Laboratories (USA)
        11.2.1 Abbott Laboratories (USA) Corporation Information
        11.2.2 Abbott Laboratories (USA) Overview
        11.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Abbott Laboratories (USA) Recent Developments
    11.3 Amgen, Inc. (USA)
        11.3.1 Amgen, Inc. (USA) Corporation Information
        11.3.2 Amgen, Inc. (USA) Overview
        11.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Amgen, Inc. (USA) Recent Developments
    11.4 Eli Lilly and Company (USA)
        11.4.1 Eli Lilly and Company (USA) Corporation Information
        11.4.2 Eli Lilly and Company (USA) Overview
        11.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Eli Lilly and Company (USA) Recent Developments
    11.5 F. Hoffmann-La Roche Ltd (Switzerland)
        11.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
        11.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Overview
        11.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments
    11.6 Genentech, Inc. (USA)
        11.6.1 Genentech, Inc. (USA) Corporation Information
        11.6.2 Genentech, Inc. (USA) Overview
        11.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Genentech, Inc. (USA) Recent Developments
    11.7 GlaxoSmithKline plc. (UK)
        11.7.1 GlaxoSmithKline plc. (UK) Corporation Information
        11.7.2 GlaxoSmithKline plc. (UK) Overview
        11.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 GlaxoSmithKline plc. (UK) Recent Developments
    11.8 Janssen Biologics B.V. (USA)
        11.8.1 Janssen Biologics B.V. (USA) Corporation Information
        11.8.2 Janssen Biologics B.V. (USA) Overview
        11.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Janssen Biologics B.V. (USA) Recent Developments
    11.9 Actelion Pharmaceuticals
        11.9.1 Actelion Pharmaceuticals Corporation Information
        11.9.2 Actelion Pharmaceuticals Overview
        11.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Actelion Pharmaceuticals Recent Developments
    11.10 AstraZeneca Plc. (UK)
        11.10.1 AstraZeneca Plc. (UK) Corporation Information
        11.10.2 AstraZeneca Plc. (UK) Overview
        11.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 AstraZeneca Plc. (UK) Recent Developments
    11.11 Boehringer Ingelheim GmbH (Germany)
        11.11.1 Boehringer Ingelheim GmbH (Germany) Corporation Information
        11.11.2 Boehringer Ingelheim GmbH (Germany) Overview
        11.11.3 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Boehringer Ingelheim GmbH (Germany) Recent Developments
    11.12 Bristol-Myers Squibb Company (USA)
        11.12.1 Bristol-Myers Squibb Company (USA) Corporation Information
        11.12.2 Bristol-Myers Squibb Company (USA) Overview
        11.12.3 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Bristol-Myers Squibb Company (USA) Recent Developments
    11.13 Allergan, Inc. (USA)
        11.13.1 Allergan, Inc. (USA) Corporation Information
        11.13.2 Allergan, Inc. (USA) Overview
        11.13.3 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Allergan, Inc. (USA) Recent Developments
    11.14 Novartis AG (Switzerland)
        11.14.1 Novartis AG (Switzerland) Corporation Information
        11.14.2 Novartis AG (Switzerland) Overview
        11.14.3 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Novartis AG (Switzerland) Recent Developments
    11.15 Novo Nordisk A/S (Denmark)
        11.15.1 Novo Nordisk A/S (Denmark) Corporation Information
        11.15.2 Novo Nordisk A/S (Denmark) Overview
        11.15.3 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Novo Nordisk A/S (Denmark) Recent Developments
    11.16 Pfizer, Inc. (USA)
        11.16.1 Pfizer, Inc. (USA) Corporation Information
        11.16.2 Pfizer, Inc. (USA) Overview
        11.16.3 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.16.4 Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.16.5 Pfizer, Inc. (USA) Recent Developments
    11.17 Sanofi S.A (France)
        11.17.1 Sanofi S.A (France) Corporation Information
        11.17.2 Sanofi S.A (France) Overview
        11.17.3 Sanofi S.A (France) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.17.4 Sanofi S.A (France) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.17.5 Sanofi S.A (France) Recent Developments
    11.18 Shionogi Inc. (USA)
        11.18.1 Shionogi Inc. (USA) Corporation Information
        11.18.2 Shionogi Inc. (USA) Overview
        11.18.3 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.18.4 Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.18.5 Shionogi Inc. (USA) Recent Developments
    11.19 Takeda
        11.19.1 Takeda Corporation Information
        11.19.2 Takeda Overview
        11.19.3 Takeda Pediatric Drugs and Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
        11.19.4 Takeda Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
        11.19.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Pediatric Drugs and Vaccines Industry Chain Analysis
    12.2 Pediatric Drugs and Vaccines Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Pediatric Drugs and Vaccines Production Mode & Process
    12.4 Pediatric Drugs and Vaccines Sales and Marketing
        12.4.1 Pediatric Drugs and Vaccines Sales Channels
        12.4.2 Pediatric Drugs and Vaccines Distributors
    12.5 Pediatric Drugs and Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Pediatric Drugs and Vaccines Industry Trends
    13.2 Pediatric Drugs and Vaccines Market Drivers
    13.3 Pediatric Drugs and Vaccines Market Challenges
    13.4 Pediatric Drugs and Vaccines Market Restraints
14 Key Findings in The Global Pediatric Drugs and Vaccines Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Pediatric Drugs and Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Diphtheria
    Table 3. Major Manufacturers of Influenza
    Table 4. Major Manufacturers of Hepatitis
    Table 5. Major Manufacturers of Pneumococcal Diseases
    Table 6. Major Manufacturers of Meningococcal Diseases
    Table 7. Major Manufacturers of Mumps
    Table 8. Major Manufacturers of Others
    Table 9. Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 10. Global Pediatric Drugs and Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 11. Global Pediatric Drugs and Vaccines Sales by Region (2017-2022) & (Kg)
    Table 12. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2017-2022)
    Table 13. Global Pediatric Drugs and Vaccines Sales by Region (2023-2028) & (Kg)
    Table 14. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2023-2028)
    Table 15. Global Pediatric Drugs and Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 16. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2017-2022)
    Table 17. Global Pediatric Drugs and Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 18. Global Pediatric Drugs and Vaccines Revenue Market Share by Region (2023-2028)
    Table 19. Global Pediatric Drugs and Vaccines Sales by Manufacturers (2017-2022) & (Kg)
    Table 20. Global Pediatric Drugs and Vaccines Sales Share by Manufacturers (2017-2022)
    Table 21. Global Pediatric Drugs and Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 22. Global Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 23. Pediatric Drugs and Vaccines Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 24. Global Pediatric Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 25. Global Pediatric Drugs and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drugs and Vaccines as of 2021)
    Table 26. Pediatric Drugs and Vaccines Manufacturing Base Distribution and Headquarters
    Table 27. Manufacturers Pediatric Drugs and Vaccines Product Offered
    Table 28. Date of Manufacturers Enter into Pediatric Drugs and Vaccines Market
    Table 29. Mergers & Acquisitions, Expansion Plans
    Table 30. Global Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
    Table 31. Global Pediatric Drugs and Vaccines Sales by Type (2023-2028) & (Kg)
    Table 32. Global Pediatric Drugs and Vaccines Sales Share by Type (2017-2022)
    Table 33. Global Pediatric Drugs and Vaccines Sales Share by Type (2023-2028)
    Table 34. Global Pediatric Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 35. Global Pediatric Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 36. Global Pediatric Drugs and Vaccines Revenue Share by Type (2017-2022)
    Table 37. Global Pediatric Drugs and Vaccines Revenue Share by Type (2023-2028)
    Table 38. Pediatric Drugs and Vaccines Price by Type (2017-2022) & (USD/Kg)
    Table 39. Global Pediatric Drugs and Vaccines Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 40. Global Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
    Table 41. Global Pediatric Drugs and Vaccines Sales by Application (2023-2028) & (Kg)
    Table 42. Global Pediatric Drugs and Vaccines Sales Share by Application (2017-2022)
    Table 43. Global Pediatric Drugs and Vaccines Sales Share by Application (2023-2028)
    Table 44. Global Pediatric Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 45. Global Pediatric Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 46. Global Pediatric Drugs and Vaccines Revenue Share by Application (2017-2022)
    Table 47. Global Pediatric Drugs and Vaccines Revenue Share by Application (2023-2028)
    Table 48. Pediatric Drugs and Vaccines Price by Application (2017-2022) & (USD/Kg)
    Table 49. Global Pediatric Drugs and Vaccines Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 50. North America Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
    Table 51. North America Pediatric Drugs and Vaccines Sales by Type (2023-2028) & (Kg)
    Table 52. North America Pediatric Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 53. North America Pediatric Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 54. North America Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
    Table 55. North America Pediatric Drugs and Vaccines Sales by Application (2023-2028) & (Kg)
    Table 56. North America Pediatric Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 57. North America Pediatric Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 58. North America Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)
    Table 59. North America Pediatric Drugs and Vaccines Sales by Country (2023-2028) & (Kg)
    Table 60. North America Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 61. North America Pediatric Drugs and Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 62. Europe Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
    Table 63. Europe Pediatric Drugs and Vaccines Sales by Type (2023-2028) & (Kg)
    Table 64. Europe Pediatric Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 65. Europe Pediatric Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 66. Europe Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
    Table 67. Europe Pediatric Drugs and Vaccines Sales by Application (2023-2028) & (Kg)
    Table 68. Europe Pediatric Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 69. Europe Pediatric Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 70. Europe Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)
    Table 71. Europe Pediatric Drugs and Vaccines Sales by Country (2023-2028) & (Kg)
    Table 72. Europe Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 73. Europe Pediatric Drugs and Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
    Table 75. Asia Pacific Pediatric Drugs and Vaccines Sales by Type (2023-2028) & (Kg)
    Table 76. Asia Pacific Pediatric Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Pediatric Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
    Table 79. Asia Pacific Pediatric Drugs and Vaccines Sales by Application (2023-2028) & (Kg)
    Table 80. Asia Pacific Pediatric Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Pediatric Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 82. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2017-2022) & (Kg)
    Table 83. Asia Pacific Pediatric Drugs and Vaccines Sales by Region (2023-2028) & (Kg)
    Table 84. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 85. Asia Pacific Pediatric Drugs and Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 86. Latin America Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
    Table 87. Latin America Pediatric Drugs and Vaccines Sales by Type (2023-2028) & (Kg)
    Table 88. Latin America Pediatric Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 89. Latin America Pediatric Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 90. Latin America Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
    Table 91. Latin America Pediatric Drugs and Vaccines Sales by Application (2023-2028) & (Kg)
    Table 92. Latin America Pediatric Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 93. Latin America Pediatric Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 94. Latin America Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)
    Table 95. Latin America Pediatric Drugs and Vaccines Sales by Country (2023-2028) & (Kg)
    Table 96. Latin America Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 97. Latin America Pediatric Drugs and Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2017-2022) & (Kg)
    Table 99. Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2023-2028) & (Kg)
    Table 100. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2017-2022) & (Kg)
    Table 103. Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2023-2028) & (Kg)
    Table 104. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 106. Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2017-2022) & (Kg)
    Table 107. Middle East and Africa Pediatric Drugs and Vaccines Sales by Country (2023-2028) & (Kg)
    Table 108. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 109. Middle East and Africa Pediatric Drugs and Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 110. Merck & Co., Inc. (USA) Corporation Information
    Table 111. Merck & Co., Inc. (USA) Description and Major Businesses
    Table 112. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 113. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Merck & Co., Inc. (USA) Recent Developments
    Table 115. Abbott Laboratories (USA) Corporation Information
    Table 116. Abbott Laboratories (USA) Description and Major Businesses
    Table 117. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 118. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Abbott Laboratories (USA) Recent Developments
    Table 120. Amgen, Inc. (USA) Corporation Information
    Table 121. Amgen, Inc. (USA) Description and Major Businesses
    Table 122. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 123. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Amgen, Inc. (USA) Recent Developments
    Table 125. Eli Lilly and Company (USA) Corporation Information
    Table 126. Eli Lilly and Company (USA) Description and Major Businesses
    Table 127. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 128. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Eli Lilly and Company (USA) Recent Developments
    Table 130. F. Hoffmann-La Roche Ltd (Switzerland) Corporation Information
    Table 131. F. Hoffmann-La Roche Ltd (Switzerland) Description and Major Businesses
    Table 132. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 133. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. F. Hoffmann-La Roche Ltd (Switzerland) Recent Developments
    Table 135. Genentech, Inc. (USA) Corporation Information
    Table 136. Genentech, Inc. (USA) Description and Major Businesses
    Table 137. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 138. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Genentech, Inc. (USA) Recent Developments
    Table 140. GlaxoSmithKline plc. (UK) Corporation Information
    Table 141. GlaxoSmithKline plc. (UK) Description and Major Businesses
    Table 142. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 143. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. GlaxoSmithKline plc. (UK) Recent Developments
    Table 145. Janssen Biologics B.V. (USA) Corporation Information
    Table 146. Janssen Biologics B.V. (USA) Description and Major Businesses
    Table 147. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 148. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Janssen Biologics B.V. (USA) Recent Developments
    Table 150. Actelion Pharmaceuticals Corporation Information
    Table 151. Actelion Pharmaceuticals Description and Major Businesses
    Table 152. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 153. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Actelion Pharmaceuticals Recent Developments
    Table 155. AstraZeneca Plc. (UK) Corporation Information
    Table 156. AstraZeneca Plc. (UK) Description and Major Businesses
    Table 157. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 158. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. AstraZeneca Plc. (UK) Recent Developments
    Table 160. Boehringer Ingelheim GmbH (Germany) Corporation Information
    Table 161. Boehringer Ingelheim GmbH (Germany) Description and Major Businesses
    Table 162. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 163. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Boehringer Ingelheim GmbH (Germany) Recent Developments
    Table 165. Bristol-Myers Squibb Company (USA) Corporation Information
    Table 166. Bristol-Myers Squibb Company (USA) Description and Major Businesses
    Table 167. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 168. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Bristol-Myers Squibb Company (USA) Recent Developments
    Table 170. Allergan, Inc. (USA) Corporation Information
    Table 171. Allergan, Inc. (USA) Description and Major Businesses
    Table 172. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 173. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Allergan, Inc. (USA) Recent Developments
    Table 175. Novartis AG (Switzerland) Corporation Information
    Table 176. Novartis AG (Switzerland) Description and Major Businesses
    Table 177. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 178. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Novartis AG (Switzerland) Recent Developments
    Table 180. Novo Nordisk A/S (Denmark) Corporation Information
    Table 181. Novo Nordisk A/S (Denmark) Description and Major Businesses
    Table 182. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 183. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 184. Novo Nordisk A/S (Denmark) Recent Developments
    Table 185. Pfizer, Inc. (USA) Corporation Information
    Table 186. Pfizer, Inc. (USA) Description and Major Businesses
    Table 187. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 188. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 189. Pfizer, Inc. (USA) Recent Developments
    Table 190. Sanofi S.A (France) Corporation Information
    Table 191. Sanofi S.A (France) Description and Major Businesses
    Table 192. Sanofi S.A (France) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 193. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 194. Sanofi S.A (France) Recent Developments
    Table 195. Shionogi Inc. (USA) Corporation Information
    Table 196. Shionogi Inc. (USA) Description and Major Businesses
    Table 197. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 198. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 199. Shionogi Inc. (USA) Recent Developments
    Table 200. Takeda Corporation Information
    Table 201. Takeda Description and Major Businesses
    Table 202. Takeda Pediatric Drugs and Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 203. Takeda Pediatric Drugs and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 204. Takeda Recent Developments
    Table 205. Key Raw Materials Lists
    Table 206. Raw Materials Key Suppliers Lists
    Table 207. Pediatric Drugs and Vaccines Distributors List
    Table 208. Pediatric Drugs and Vaccines Customers List
    Table 209. Pediatric Drugs and Vaccines Market Trends
    Table 210. Pediatric Drugs and Vaccines Market Drivers
    Table 211. Pediatric Drugs and Vaccines Market Challenges
    Table 212. Pediatric Drugs and Vaccines Market Restraints
    Table 213. Research Programs/Design for This Report
    Table 214. Key Data Information from Secondary Sources
    Table 215. Key Data Information from Primary Sources
List of Figures
    Figure 1. Pediatric Drugs and Vaccines Product Picture
    Figure 3. Global Pediatric Drugs and Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Diphtheria Product Picture
    Figure 4. Influenza Product Picture
    Figure 5. Hepatitis Product Picture
    Figure 6. Pneumococcal Diseases Product Picture
    Figure 7. Meningococcal Diseases Product Picture
    Figure 8. Mumps Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Pediatric Drugs and Vaccines Market Share by Application in 2021 & 2028
    Figure 11. Newborn
    Figure 12. Infant
    Figure 13. Child
    Figure 14. Pediatric Drugs and Vaccines Report Years Considered
    Figure 15. Global Pediatric Drugs and Vaccines Sales 2017-2028 (Kg)
    Figure 16. Global Pediatric Drugs and Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Pediatric Drugs and Vaccines Revenue 2017-2028 (US$ Million)
    Figure 18. Global Pediatric Drugs and Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2017-2022)
    Figure 20. Global Pediatric Drugs and Vaccines Sales Market Share by Region (2023-2028)
    Figure 21. North America Pediatric Drugs and Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 22. North America Pediatric Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Pediatric Drugs and Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 24. Europe Pediatric Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Pediatric Drugs and Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 26. Asia-Pacific Pediatric Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Pediatric Drugs and Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 28. Latin America Pediatric Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Pediatric Drugs and Vaccines Sales YoY (2017-2028) & (Kg)
    Figure 30. Middle East & Africa Pediatric Drugs and Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Pediatric Drugs and Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Pediatric Drugs and Vaccines in the World: Market Share by Pediatric Drugs and Vaccines Revenue in 2021
    Figure 33. Global Pediatric Drugs and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2028)
    Figure 35. Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2028)
    Figure 36. Global Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2028)
    Figure 37. Global Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2028)
    Figure 38. North America Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2028)
    Figure 39. North America Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2028)
    Figure 40. North America Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2028)
    Figure 41. North America Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2028)
    Figure 42. North America Pediatric Drugs and Vaccines Sales Share by Country (2017-2028)
    Figure 43. North America Pediatric Drugs and Vaccines Revenue Share by Country (2017-2028)
    Figure 44. U.S. Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2028)
    Figure 47. Europe Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2028)
    Figure 49. Europe Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Pediatric Drugs and Vaccines Sales Share by Country (2017-2028)
    Figure 51. Europe Pediatric Drugs and Vaccines Revenue Share by Country (2017-2028)
    Figure 52. Germany Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 53. France Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Pediatric Drugs and Vaccines Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Pediatric Drugs and Vaccines Revenue Share by Region (2017-2028)
    Figure 63. China Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. India Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Pediatric Drugs and Vaccines Sales Share by Country (2017-2028)
    Figure 78. Latin America Pediatric Drugs and Vaccines Revenue Share by Country (2017-2028)
    Figure 79. Mexico Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Pediatric Drugs and Vaccines Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Pediatric Drugs and Vaccines Revenue Share by Country (2017-2028)
    Figure 88. Turkey Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 90. U.A.E Pediatric Drugs and Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 91. Pediatric Drugs and Vaccines Value Chain
    Figure 92. Pediatric Drugs and Vaccines Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Takeda
Frequently Asked Questions
Pediatric Drugs and Vaccines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pediatric Drugs and Vaccines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pediatric Drugs and Vaccines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Pepper

Pepper market is segmented by Type and by Application. Players, stakeholders, and other participa ... Read More

Peptic Ulcer Testing

Peptic Ulcer Testing market is segmented by players, region (country), by Type and by Application ... Read More